Neuronetics' board promoted Cory Anderson from Senior Vice President and Chief Technology Officer to Executive Vice President, General Manager of Greenbrook, effective July 1, 2026. Greenbrook is the large TMS and Spravato clinic network Neuronetics acquired in late 2024 and one of the largest TMS providers in the United States.
Anderson, 49, has been with Neuronetics since 2021 in progressively senior R&D and clinical roles and brings more than 25 years of medical-device leadership experience. The move puts a long-tenured NeuroStar technology executive directly in charge of the company's clinic-operations segment, which management has flagged as a key driver in its 2026 revenue guidance of $160–166 million.
The promotion comes during a broader leadership transition year for Neuronetics, with Dan Reuvers having taken over as President and CEO in March 2026 following Keith Sullivan's retirement.
For the TMS clinic market, leadership continuity at Greenbrook matters for referral partners and patients who rely on the network for treatment access.
Source
Reporting based on coverage from Neuronetics. This article is editorial summary intended for general information; it is not medical advice.
